

Simon-Kucher’s global expert team has unrivaled expertise in helping pharmaceutical and biotechnology companies achieve their strategic goals while improving the health of people around the world.
Simon-Kucher advises pharmaceutical and biotechnology clients on their most challenging strategic priorities regarding their TopLine Power®. We help our clients grow their businesses, communicate the value of their products, better meet the needs of their customers, attain patient access for their products, and achieve their strategic goals.
Strategy
|
Pricing & Market Access
|
Marketing
|
Transformation
|
Sales
|
Digital
|
Your Market Access and Pricing (MAP) function plays a pivotal role in a product’s success. Is your MAP organization set up to seize opportunities and face challenges? Are you meeting all the requirements to future-proof the MAP organization to ensure success?
Pharmaceuticals and Biotechnology Experts
Featured Resources
Blog post
March 15, 2021
ATMPs – Prepare for Successful Access in a Changing Environment
Blog post
January 05, 2021
Blog post
January 05, 2021
Blog post
January 05, 2021
“COVID-friendly” Cancer Treatments – What Will Be the Lasting Impact of Interim Access?
Blog post
January 05, 2021
Blog post
January 05, 2021
Blog post
January 05, 2021
Blog post
November 30, 2020
Blog post
November 09, 2020
Video
October 05, 2020
Blog post
August 24, 2020
COVID-19: How CDMOs Can Overcome Their 2 Key Commercial Challenges
Blog post
June 30, 2020
Blog post
May 06, 2020
Overcoming New Challenges in Biopharmaceutical Launch Strategies amid COVID-19
Blog post
April 21, 2020
Blog post
April 09, 2020
Simon-Kucher Perspectives
February 18, 2020
Blog post
October 10, 2019
Key Account Management: Tackling the Challenges of a Dynamic Pharma Market
Blog post
October 09, 2019
Blog post
February 04, 2019
Blog post
June 01, 2018
Pharmaceutical Industry: Organization of the Pricing and Market Access Function
Simon-Kucher Perspectives
March 13, 2018
Featured Resource